You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 9,212,350


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,212,350
Title:Method of cloning stable stress tolerant superoxide dismutase using universal primers
Abstract: The present invention relates to a method of cloning stable stress tolerant superoxide dismutase from diverse plant species using universal primers.
Inventor(s): Bhardwaj; Pardeep Kumar (Palampur, IN), Kumar; Arun (Palampur, IN), Kishore; Amit (Palampur, IN), Ghawana; Sanjay (Palampur, IN), Rani; Arti (Palampur, IN), Singh; Kashmir (Palampur, IN), Singh; Harsharan (Palampur, IN), Singh; Ravi Shankar (Palampur, IN), Kumar; Hitesh (Palampur, IN), Sood; Payal (Palampur, IN), Dutt; Som (Palampur, IN), Kumar; Sanjay (Palampur, IN), Ahuja; Paramvir Singh (Palampur, IN)
Assignee: Council of Scientific and Industrial Research (New Delhi, IN)
Application Number:12/935,881
Patent Claims:1. A degenerate primer set comprising at least as primers two polynculeotides comprising SEQ ID NOs:24 and 25 or SEQ ID NOs:26 and 27, wherein the primer set is adapted to amplify stress tolerant superoxide dismutase (SOD) from plant species.

2. The primer set of claim 1, wherein the primers comprise four polynucleotides comprising SEQ ID Nos:24 to 27.

3. The primer set of claim 1 comprising at least as primers polynucleotides comprising SEQ ID NOs:24 and 25, wherein the primers comprising SEQ ID NOs:24 and 25 are further defined as: being 21 nucleotides long; having a G+C content in the range of about 38% to about 62%; having a Tm in the range of about 49.degree. C. to about 58.degree. C.; having an annealing temperature that is in the range of about 53.degree. C. to about 58.degree. C.; and having an optimal annealing temperature for SOD detection that is about 55.degree. C.

4. The primer set of claim 1 comprising at least as primers polynucleotides comprising SEQ ID NOs:26 and 27, wherein the primers comprising SEQ ID NOs:26 and 27 are further defined as: being 21 nucleotides long; having a G+C content in the range of about 33% to about 62%; having a Tm in the range of about 47.degree. C. to about 56.degree. C.; having an annealing temperature that is in the range of about 52.degree. C. to about 58.degree. C.; and having an optimal annealing temperature for SOD detection that is about 55.degree. C.

5. A method of amplifying stress tolerant SOD comprising: amplifying SOD with the primer set of claim 1, wherein the primers comprise two polynucleotides comprising SEQ ID NOs:24 and 25; and obtaining a gene product that is about 390 base pairs long.

6. A method of amplifying stress tolerant SOD comprising: amplifying SOD with the primer set of claim 1, wherein the primers comprise two polynucleotides comprising SEQ ID NOs:26 and 27; and obtaining a gene product that is about 280 base pairs long.

7. A method of obtaining stable stress tolerant superoxide dismutase (SOD) from plant species comprising: isolating the total RNA from leaf tissue; synthesizing complementary DNA from the isolated RNA; obtaining primers for amplifying the Cu/Zn SOD gene, wherein each primer comprises a nucleotide sequence selected from the group consisting of SEQ ID NOs:24 to 27; and amplifying the Cu/Zn SOD gene using the obtained primers to provide an amplified product.

8. The method of claim 7, wherein the plant species is selected from the group consisting of Camellia sinensis, Caragana jubata, Arnebia euchroma, Rheum emodi, Picrorhiza kurrooa, Stevia rebaudiana, Curcuma aromatica, Eragrostis atrovirens, Echinocloa crussgalia, Eleucine indica, Cynodon dactylone, Pennisetum clandistinum, Toona sinesis and Lantana camara.

9. The method of claim 8, wherein the Cu/Zn SOD gene is shorter than the full-length Cu/Zn SOD gene from the plant species.

10. The method of claim 9, wherein the Cu/Zn SOD gene comprises a nucleotide sequence selected from the group consisting of SEQ ID NOs:1 to 16.

11. The method of claim 8, wherein the Cu/Zn SOD gene is a full-length Cu/Zn SOD cDNA.

12. The method of claim 11, wherein the full-length Cu/Zn SOD cDNA comprises a nucleotide sequence selected from the group consisting of SEQ ID NOs:20 to 23.

13. The method of claim 7, wherein the amplifying is by polymerase chain reaction (PCR).

14. The method of claim 13, wherein the PCR comprises: incubating a sample comprising the synthesized complementary DNA and obtained primers at 94.degree. C. for 3 min; performing 35 amplification cycles, wherein each cycle comprises incubating the sample and incubating the sample at 72.degree. C. for 7 min.

15. The method of claim 7, further comprising: ligating the amplified product into a vector to provide a recombinant plasmid; transforming the recombinant plasmid into a cell; and purifying the stable stress tolerant superoxide dismutase from the transformed cells.

16. The method of claim 15, wherein the purified stable stress tolerant superoxide dismutase is further defined as having enzymatic activity under one or more stress parameters selected from the group consisting of high temperature, high pressure, and sub-zero temperature.

17. The method of claim 16, wherein the purified stable stress tolerant superoxide dismutase is further defined as having enzymatic activity at high temperature, and the high temperature is further defined as in the range of about 100.degree. C. to about 121.degree. C.

18. The method of claim 16, wherein the purified stable stress tolerant superoxide dismutase is further defined as having enzymatic activity at high pressure, and the high pressure is further defined as in the range of about 14 pounds per square inch (psi) to about 15 psi.

19. The method of claim 16, wherein the purified stable stress tolerant superoxide dismutase is further defined as having enzymatic activity at sub-zero temperature, and the sub-zero temperature is further defined as in the range of about 0.degree. C. to about minus 10.degree. C.

20. The method of claim 7, further comprising detecting expression of Cu/Zn SOD genes in an organism using the amplified Cu/Zn SOD product.

21. The method of claim 20, wherein the organism is a plant, animal, or microbe.

22. The method of claim 7, further comprising expressing the amplified product in a plant to provide a stress tolerant transgenic plant.

23. The method of claim 7, wherein the amplified product comprises a nucleotide sequence selected from the group consisting of SEQ ID NOs:1 to 23.

24. The method of claim 23, further comprising using the amplified product to amplify an upstream promoter region of the Cu/Zn SOD gene.

25. The method of claim 23, further comprising using the amplified product to identify and clone one or more intron regions of the Cu/Zn SOD gene.

26. The method of claim 23, further comprising using the amplified product to synthesize SOD proteins.

27. The method of claim 23, further comprising: providing the amplified product to an animal; and obtaining antibodies produced by the animal against the amplified product.

28. The method of claim 27, wherein the animal is a rabbit or goat.

29. A kit for PCR-based detection and identification of stress tolerant superoxide dismutase in diverse plant species comprising the degenerate primer set of claim 1.

Details for Patent 9,212,350

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2028-03-31
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2028-03-31
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2028-03-31
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.